{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T02:49:54Z","timestamp":1769914194930,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2501200"],"award-info":[{"award-number":["2021YFC2501200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.heliyon.2023.e17876","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T21:33:55Z","timestamp":1688420035000},"page":"e17876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effects of different levodopa doses on blood pressure in older patients with early and middle stages of Parkinson's disease"],"prefix":"10.1016","volume":"9","author":[{"given":"Dan","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5197-4356","authenticated-orcid":false,"given":"Piu","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e17876_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/jnnp.68.2.254","article-title":"Mortality from Parkinson's disease","volume":"68","author":"Clarke","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.heliyon.2023.e17876_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(05)70801-1","article-title":"Parkinson's disease in China: prevalence in Beijing, Xian, Shanghai Met.","volume":"365","author":"Zhang","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e17876_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e17876_bib4","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","article-title":"Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis","volume":"17","author":"Velseboer","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.heliyon.2023.e17876_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-133-5-200009050-00009","article-title":"Cardiac sympathetic denervation in Parkinson disease","volume":"133","author":"Goldstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.heliyon.2023.e17876_bib6","doi-asserted-by":"crossref","first-page":"e1526","DOI":"10.1212\/WNL.0000000000008314","article-title":"Orthostatic hypotension in Parkinson disease: a 7-year prospective population-based study","volume":"93","author":"Hiorth","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e17876_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.parkreldis.2014.12.016","article-title":"Severity of orthostatic hypotension in the course of Parkinson's disease: no correlation with the duration of the disease","volume":"21","author":"Jost","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.heliyon.2023.e17876_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40266-018-0629-0","article-title":"Factors to consider in the selection of dopamine agonists for older persons with Parkinson's disease","volume":"36","author":"Latt","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/j.heliyon.2023.e17876_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0404.2006.00742.x","article-title":"Selegiline and blood pressure in patients with Parkinson's disease","volume":"115","author":"Pursiainen","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.heliyon.2023.e17876_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3233\/JPD-191907","article-title":"Cardiovascular Adverse Events Reported in placebo arm of randomized controlled trials in Parkinson's disease","volume":"10","author":"Alves","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.heliyon.2023.e17876_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.parkreldis.2017.02.007","article-title":"Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: results of a levodopa challenge test","volume":"39","author":"Fabbri","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.heliyon.2023.e17876_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2016.02.021","article-title":"Do patients with late-stage Parkinson's disease still respond to levodopa","volume":"26","author":"Fabbri","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.heliyon.2023.e17876_bib13","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1007\/s00415-020-09810-7","article-title":"Levodopa challenge test: indications, protocol, and guide","volume":"268","author":"Saranza","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.heliyon.2023.e17876_bib14","first-page":"165","article-title":"Parkinson's Disease Society Brain Bank, London: Overview and Research","volume":"vol. 39","author":"Daniel","year":"1993","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.heliyon.2023.e17876_bib15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/00004872-199110000-00002","article-title":"Malignant hypertension","volume":"9","author":"Kincaid-Smith","year":"1991","journal-title":"Hypertens"},{"key":"10.1016\/j.heliyon.2023.e17876_bib16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale","volume":"28","author":"Stebbins","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.heliyon.2023.e17876_bib17","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mds.22017","article-title":"The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease","volume":"23","author":"Gill","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.heliyon.2023.e17876_bib18","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/1099-1166(200007)15:7<644::AID-GPS167>3.0.CO;2-L","article-title":"The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease","volume":"15","author":"Leentjens","year":"2000","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.heliyon.2023.e17876_bib19","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/mds.21740","article-title":"The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument","volume":"22","author":"Stiasny-Kolster","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.heliyon.2023.e17876_bib20","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.heliyon.2023.e17876_bib21","first-page":"1470","article-title":"The Consensus Committee of the American Autonomic Society and the American Academy of Neurology","volume":"46","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e17876_bib22","article-title":"Effect of Acute Levodopa Up-Titration on blood pressure in patients with early stage Parkinson's disease: results of a levodopa challenge test","volume":"13","author":"He","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2023.e17876_bib23","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1291\/hypres.18.SupplementI_S175","article-title":"Effects of acute levodopa administration on blood pressure and heart variability in never treated parkinsonians","volume":"18","author":"Senard","year":"1995","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.heliyon.2023.e17876_bib24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.parkreldis.2014.04.007","article-title":"Cardiovascular effects of levodopa in Parkinson's disease","volume":"20","author":"Noack","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.heliyon.2023.e17876_bib25","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/jnnp.2006.103739","article-title":"Psychiatry. Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease","volume":"78","author":"Ludwig","year":"2007","journal-title":"J. Neurol. Neurosurg"},{"key":"10.1016\/j.heliyon.2023.e17876_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1532-5415.1974.tb05836.x","article-title":"Effects of levodopa therapy in Patients with Parkinson's disease: statistical evidence for reduced tolerance to levodopa in the elderly","volume":"22","author":"Grad","year":"1974","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.heliyon.2023.e17876_bib27","first-page":"296","volume":"100","author":"Mesec","year":"1999","journal-title":"Acta neurol scand. The deterioration of cardiovascular reflexes in Parkinson's disease"},{"key":"10.1016\/j.heliyon.2023.e17876_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0404.1990.tb01568.x","article-title":"Cardiovascular reflexes in Parkinson's disease: long-term effects of levodopa treatment on de novo patients","volume":"81","author":"Camerlingo","year":"1990","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.heliyon.2023.e17876_bib29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4103\/0028-3886.86536","article-title":"Effect of a single dose of standard levodopa on cardiac autonomic function in Parkinson's disease","volume":"59","author":"Sriranjini","year":"2011","journal-title":"Neurol. India"},{"key":"10.1016\/j.heliyon.2023.e17876_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0306-4522(94)90321-2","article-title":"Baroreceptor-aortic nerve-mediated release of endogenous L-3,4-dihydroxyphenylalanine and its tonic depressor function in the nucleus tractus solitarii of rats","volume":"62","author":"Yue","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.heliyon.2023.e17876_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0304-3940(83)90482-2","article-title":"Brainstem projections of aortic baroreceptor afferent fibers in the rat","volume":"36","author":"Ciriello","year":"1983","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.heliyon.2023.e17876_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/bmj.4.5679.333","article-title":"Action of dopamine on the human iris","volume":"4","author":"Spiers","year":"1969","journal-title":"Br. Med. J."},{"key":"10.1016\/j.heliyon.2023.e17876_bib33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.HYP.34.3.398","article-title":"In vivo evidence that endogenous dopamine modulates sympathetic activity in man","volume":"34","author":"Mannelli","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.heliyon.2023.e17876_bib34","first-page":"22","article-title":"Myocardial imaging with a radioiodinated norepinephrine storage analog","volume":"22","author":"Wieland","year":"1981","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.heliyon.2023.e17876_bib35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1071-3581(05)80043-1","article-title":"Sympathetic tone assessed by washout of iodine 125-labeled metaiodobenzylguanidine from the murine left ventricle--influence of immobilization stress and inhibition of the renin-angiotensin system","volume":"2","author":"Takatsu","year":"1995","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e17876_bib36","first-page":"71","article-title":"Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG","volume":"41","author":"Takatsu","year":"2000","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.heliyon.2023.e17876_bib37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/ane.12104","article-title":"Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease","volume":"128","author":"Asayama","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.heliyon.2023.e17876_bib38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/cpt1971122part2376","article-title":"Cardiovascular effects of levodopa","volume":"12","author":"Goldberg","year":"1971","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.heliyon.2023.e17876_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.parkreldis.2019.10.023","article-title":"Cardiovascular autonomic function and MCI in Parkinson's disease","volume":"69","author":"Cicero","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.heliyon.2023.e17876_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.parkreldis.2011.09.009","article-title":"Cognitive impairment is common in Parkinson's disease without dementia in the early and middle stages in a Han Chinese cohort","volume":"18","author":"Wu","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.heliyon.2023.e17876_bib41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/00207454.2012.642038","article-title":"Differences in motor and cognitive function in patients with Parkinson's disease with and without orthostatic hypotension","volume":"122","author":"Hohler","year":"2012","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.heliyon.2023.e17876_bib42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00702-006-0615-2","article-title":"Orthostatic hypotension and attention in Parkinson's disease with and without dementia","volume":"114","author":"Peralta","year":"2007","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.heliyon.2023.e17876_bib43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archneur.58.6.977","article-title":"Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease","volume":"58","author":"Ballard","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.heliyon.2023.e17876_bib44","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/j.1468-1331.2007.01982.x","article-title":"Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing","volume":"14","author":"Wullner","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.heliyon.2023.e17876_bib45","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/brain\/awz111","article-title":"Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study","volume":"142","author":"Fereshtehnejad","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.heliyon.2023.e17876_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105626","article-title":"Clinical and imaging evidence of brain-first and body-first Parkinson's disease","volume":"164","author":"Horsager","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.heliyon.2023.e17876_bib47","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.heliyon.2023.e17876_bib48","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3233\/JPD-212761","article-title":"Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson's Disease Subtypes","volume":"11","author":"Knudsen","year":"2021","journal-title":"J Parkinsons Dis"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023050843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023050843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T19:05:22Z","timestamp":1766171122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023050843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2405844023050843"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17876","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of different levodopa doses on blood pressure in older patients with early and middle stages of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e17876"}}